Rosa Resino

Rosa Resino

Auto-generated profile, based on publicly available information

Rosa Resino

Universidad Complutense de Madrid

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2006 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SRSalvador Resino
Salvador Resino
RRRosa Resino
Rosa Resino
JBJosé María Bellón-Cano
José María Bellón-Cano
DMDariela Micheloud
Dariela Micheloud
MGMa Dolores Gurbindo Gutierrez
Ma Dolores Gurbindo Gutierrez
SISpanish Group of Pediatric HIV Infection
Spanish Group of Pediatric HIV Infection
Background. Use of antiretroviral therapy has resulted in a decrease in morbidity and mortality rates in human immunodeficiency virus type 1 (HIV-1)—infected children. Methods. We performed a retrospective study involving 427 children to determine the effectiveness of different antiretroviral therapy protocols on clinical outcome. The follow-up period was divided into 5 calendar periods (CPs): CP1 (1980–1989), before antiretroviral therapy was administered; CP2 (1990–1993), when monotherapy was administered; CP3 (1994–1996), when combined therapy was administered; CP4 (1997–1998), when ⩽50% of children were receiving highly active antiretroviral therapy (HAART); and CP5 (1999–2003), when ⩾60% of children were receiving HAART. Results. Children experienced a progressive increase in the CD4+ cell count and decrease in the viral load from 1997 onwards. A lower number of AIDS cases and deaths occurred during CP5 than during the other CPs (P < .01), with a relative risk of an absence of AIDS of >20 and a relative risk of survival of >30. The AIDS rate was >50% in CP1; we observed a very strong decrease to 14% in CP2, to 16% in CP3, to 7% in CP4, and to 2% in CP5. The mortality rates in CP2 and CP3 were >6% and thereafter decreased to 0.5% in CP5. The relative risks for no hospital admission in CP4 and CP5 were >3.5. The total rates of hospital admission in CP1, CP2, and CP3 were >30%; we observed a decrease in CP4 and CP5. The duration of hospitalization decreased during the follow-up period, and it was higher in CP1 (∼30 days) than in the other periods. Conclusions. We observed that HAART produces a decrease in adverse clinical outcomes (i.e., hospital admission, AIDS, and death) in children with vertical HIV-1 infection in Madrid, Spain.

1 April 2007 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
SGSara Guillén-Martín
Sara Guillén-Martín
JRJosé Tomás Ramos
José Tomás Ramos
RRRosa Resino
Rosa Resino
JBJosé María Bellón
José María Bellón
MMMaría Angeles Muñoz
María Angeles Muñoz
There are few data on long-term effects of highly active antiretroviral therapy (HAART) on weight and height in HIV-infected children. Our objective was to assess the effect of HAART on the weight and height of HIV-infected children over time in the Madrid cohort, and analyze possible factors associated with the effect. This was a retrospective study of HIV-infected children starting HAART in 1997 or later. Serial measurements of weight, height and body mass index (BMI) were performed and converted to z-scores using the Spanish revised reference data. Changes from baseline in weight, height and BMI at 12, 24, 36, 48 and 60 months were determined. Associations of z-scores at the last visit with immunologic (CD4% above 25%) and virologic responses (more than 50% of samples below 400 copies/mL), CDC (Centers for Disease Control) clinical category, and the presence and type of lipodystrophy (lipoatrophy or lipohypertrophy) were evaluated. Twelve hundred and twelve children, 97% of them vertically-infected, received HAART starting in 1997 for a median of 71 months (4-102 months). Median age at initiation of HAART was 6 years (1 month-18 years). Thirty-nine percentage were antiretroviral naive and 61% had received NRTI therapy previously. Thirty-two percentage and 53% had CDC class C and immunologic class 3, respectively. At the final evaluation, 24% of children remained on their first combination therapy, 39% on the second and 37% had received at least 3 different HAART regimens. Fifty-one percentage were classified as virologic responders. Thirty-nine percentage of children in this study were diagnosed with lipodystrophy. At baseline, median z-score for weight, height and BMI were -0.45, -0.60 and -0.33, respectively. HAART was associated with significant increases in z-scores of weight and height but not BMI at the different time-points analyzed. Virologic nonresponders had significantly lower z-scores for weight and height but not for BMI. CDC class C was associated with lower z-scores for height. No differences in final measurements were observed for baseline CD4, immunologic response or lipoatrophy. Children with lipohypertophy had a significantly higher BMI at the last visit. HIV-infected children experienced a continued catch-up in weight and height 5 years after starting HAART. Virologic control is related to sustained growth.

15 March 2006 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SRSalvador Resino
Salvador Resino
RRRosa Resino
Rosa Resino
DMDariela Micheloud
Dariela Micheloud
DGDolores Gurbindo-Gutiérrez
Dolores Gurbindo-Gutiérrez
JLJuan Antonio Léon
Juan Antonio Léon
SISpanish Group of Paediatric HIV Infection
Spanish Group of Paediatric HIV Infection
Background. Several studies of children with human immunodeficiency virus (HIV) type 1 infection have demonstrated sustained increases in CD4+ cell c

3 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAlejandro Alvaro Meca
Alejandro Alvaro Meca
ADAsuncion Díaz
Asuncion Díaz
JMJavier de Miguel-Díez
Javier de Miguel-Díez
RRRosa Resino
Rosa Resino
SRSalvador Resino
Salvador Resino
The aim of our study was to evaluate the seasonal variations and whether short-term exposure to environmental risk factors, such as climate and air pollution, is associated with PTB-related hospital admissions in human immunodeficiency virus (HIV)-infected patients in Spain during the era of combined antiretroviral therapy (cART). A retrospective study was carried out using data from the Minimum Basic Data Set (MBDS) and the State Meteorological Agency (AEMET) of Spain. The primary outcome variable was hospital admissions with PTB diagnosis. The environmental risk factors evaluated were season, temperature, humidity, NO2, SO2, O3, PM10, and CO. Overall, HIV-infected patients had a lower frequency of PTB-related hospital admissions in summer (22.8%) and autumn (22.4%), but higher values in winter (26.6%) and spring (28.2%). Using a Bayesian temporal model, PTB-related hospital admissions were less frequent in summer-autumn and more abundant in winter-spring during the first years of follow-up. During the later years of follow-up, the seasonal trends continued resulting in the lowest values in autumn and the highest in spring. When considering short-term exposure to environmental risk factors, lower temperatures at 1 week (odds ratio (OR) = 1.03; p = 0.008), 1.5 weeks (OR = 1.03; p<0.001), 2 weeks (OR = 1.04; p<0.001), and 3 weeks (OR = 1.03; p<0.001) prior to PTB admission. In addition, higher concentration of NO2 at the time of admission were significantly associated with higher likelihoods of PTB-related hospital admission in HIV-infected patients when 1.5 weeks (OR = 1.1; p = 0.044) and 2 weeks (OR = 1.21; p<0.001) were used as controls. Finally, higher concentration of SO2 at 1.5 weeks prior to PTB admission was significantly associated with a higher likelihood of PTB-related hospital admissions (OR = 0.92; p = 0.029). In conclusion, our data suggest an apparent seasonal variation in hospital admissions of HIV-infected patients with a PTB diagnosis (summer/autumn vs. winter/spring), as well as a link to short-term exposure to environmental risk factors, such as temperature and ambient NO2 and SO2.

1 January 2015 in Journal of the International AIDS Society
Verified
Journal Article
Open access
PDF file
AMAlejandro Alvaro Meca
Alejandro Alvaro Meca
IPInes Palomares‐Sancho
Ines Palomares‐Sancho
ADAsuncion Diaz
Asuncion Diaz
RRRosa Resino
Rosa Resino
AMAngel Gil De Miguel
Angel Gil De Miguel
SRSalvador Resino
Salvador Resino
Introduction: Specific environmental factors may play a role in the development of Pneumocystis pneumonia (PCP) in HIV‐positive patients. The aim of this study was to estimate the PCP incidence and mortality in hospitalized HIV‐positive patients in Spain during the combination antiretroviral therapy (cART) era (1997 to 2011), as well as to analyze the climatological factors and air pollution levels in relation to hospital admissions and deaths.Methods: We carried out a retrospective study. Data were collected from the National Hospital Discharge Database and the State Meteorological Agency of Spain. A case‐crossover analysis was applied to identify environmental risk factors related to hospitalizations and deaths. For each patient, climatic factors and pollution levels were assigned based on readings from the nearest meteorological station to his or her postal code.Results: There were 13,139 new PCP diagnoses and 1754 deaths in hospitalized HIV‐positive patients from 1997 to 2011. The PCP incidence (events per 1000 person‐years) dropped from 11.6 in 1997 to 2000, to 5.4 in 2004 to 2011 (p<0.001). The mortality (events per 10,000 person‐years) also decreased from 14.3 in 1997 to 2000, to 7.5 in 2004 to 2011 (p<0.001). Most hospital admissions and deaths occurred in the winter season and the fewest occurred in the summer, overlapping respectively with the lowest and highest temperatures of the year in Spain. Moreover, lower temperatures prior to PCP admission, as well as higher concentrations of NO2 and particulate matter up to 10 m in size (PM10) at the time of admission were associated with higher likelihoods of hospital admission due to PCP when two weeks, one month, 1.5 months or two months were used as controls (p<0.01). Furthermore, higher concentrations of ozone at one month (p=0.007), 1.5 months (p<0.001) and two months (p=0.006) prior to admission were associated with higher likelihoods of hospital admission with PCP. For PCP‐related deaths, lower temperatures prior to admission and higher concentrations of atmospheric PM10 at the time of admission were related to higher likelihood of death when two weeks, one month and 1.5 months were used as controls (p<0.05).Conclusions: PCP was a significant health problem in the cART era (1997 to 2011), and PCP epidemiology was adversely influenced by colder climatological factors and higher ambient air pollution levels.

1 June 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SRSalvador Resino
Salvador Resino
JBJosé María Bellón-Cano
José María Bellón-Cano
RRRosa Resino
Rosa Resino
MNM. {A. } L. Navarro
M. {A. } L. Navarro
JRJosé Tomás Ramos
José Tomás Ramos
María Angeles Muñoz FernándezMaría Angeles Muñoz Fernández
María Angeles Muñoz Fernández
We performed a retrospective observational study of 253 children vertically infected with human immunodeficiency virus (1994–2001) to assess the effe